Effect of rimonabant on weight reduction and cardiovascular risk

被引：16

作者：

Hirschel, B ^{[1
]}

机构：

[1] Univ Hosp Geneva, Div Infect Dis, CH-1211 Geneva, Switzerland

来源：

LANCET | 2005年 / 366卷 / 9483期

关键词：

D O I：

10.1016/S0140-6736(05)67019-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：369 / 369

页数：1

共 50 条

[1] Effect of rimonabant on weight and cardiometabolic risk factors
Gadde, Kishore M.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (06): : 649 - 650
[2] Rimonabant reduces weight and cardiovascular risk in overweight patients with diabetes
不详
Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 (3): : 201 - 201
[3] Effect of rimonabant on weight and cardiometabolic risk factors - Reply
Pi-Sunyer, F. Xavier
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (06): : 650 - 651
[4] Effect of rimonabant on weight reduction and weight maintenance: Rimonabant in obesity-North America (RIO-NA) trial
Pi-Sunyer, FX
AMERICAN HEART JOURNAL, 2005, 149 (02) : 249 - 250
[5] Clinical design of the studies of weight reduction and metabolic effects with rimonabant: The RIO (Rimonabant in Obesity) Program
Pi-Sunyer, X
OBESITY RESEARCH, 2004, 12 : A27 - A28
[6] Effect of rimonabant on weight reduction and weight maintenance: RIO-NORTH AMERICA (RIO-NA) trial
Pi-Sunyer, FX
CIRCULATION, 2005, 111 (13) : 1727 - 1727
[7] Weight reduction by incretin mimetics improves cardiovascular risk
Ritzel, Robert
DIABETOLOGIE UND STOFFWECHSEL, 2011, 6 (01) : 21 - 22
[8] Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE)
Boesten, Jolien E. J.
Kaper, Janneke
Stoffers, Henri E. J. H.
Kroon, Abraham A.
van Schayck, Onno C. P.
FAMILY PRACTICE, 2012, 29 (05) : 521 - 527
[9] Effect of Weight Reduction on Cardiovascular Risk Factors and CD34-positive Cells in Circulation
Mikirova, Nina A.
Casciari, Joseph J.
Hunninghake, Ronald E.
Beezley, Margaret M.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2011, 8 (06): : 445 - 452
[10] Blocking the endocannabinoid system -: weight reduction and cardiovascular risk management
Bramlage, P
Böcking, W
Kirch, W
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (12) : 665 - 668

← 1 2 3 4 5 →